Ubrogepant

Ubrogepant (MK-1602) is a novel potent, selective, oral calcitonin gene-related peptide receptor (CGRP) antagonist for acute treatment of migraine.

Target : CGRP Receptor

CAS Number : 1374248-77-7

Formula Weight : 549.554

Molecular Formula : C29H26F3N5O3

Purity : >98% (HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.